Stock Events

Stock Events

Mayne Pharma Group Limited 

$2.35
14
-$0.02-0.84% Tuesday 18:51

Statistics

Day High
2.33
Day Low
2.31
52W High
4
52W Low
1.4
Volume
3,000
Avg. Volume
769
Mkt Cap
190.93M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jan 23
$0.39
Mar 11
$0.21
Nov 10
$0.39
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

26AugExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.91
-0.61
-0.3
0.01
Expected EPS
-0.3284422894854087
Actual EPS
-0.3496321146134997

Financials

-23.6%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
258.19MRevenue
-60.93MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MAYNF. It's not an investment recommendation.
Westpac Banking
7
WBC.AU
Woodside Energy Group
6
WDS.AU
ANZ Group
6
ANZ.AU
National Australia Bank Limited
6
NAB.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap42.46B
Teva Pharmaceutical Industries Ltd. is a global leader in generic medicines, directly competing with Mayne Pharma in the generics market.
Perrigo Company
PRGO
Mkt Cap2.01B
Perrigo Company plc specializes in over-the-counter healthcare products, competing with Mayne Pharma in the consumer health market.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, competing with Mayne Pharma particularly in the pharmaceutical and consumer health products sectors.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc. is a global pharmaceutical corporation that competes with Mayne Pharma in the development and distribution of both generic and specialty pharmaceuticals.
Abbvie
ABBV
Mkt Cap451.46B
AbbVie Inc. is a research-based biopharmaceutical company that competes with Mayne Pharma in the development and marketing of pharmaceutical products, particularly in areas like dermatology.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline plc is a global healthcare company that competes with Mayne Pharma in the pharmaceutical and healthcare sectors, including areas such as respiratory diseases, vaccines, and consumer healthcare products.

About

Mayne Pharma Group Limited is an Australian-headquartered specialty pharmaceutical enterprise, engaged in the development, production, and marketing of both patented (branded) and generic drug formulations. Its commercial reach spans Australia, New Zealand, North America (covering the United States and Canada), Europe, and Asia. The company's operations are divided into four main segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. Beyond its own product lines, Mayne Pharma offers sophisticated oral drug delivery technologies and comprehensive contract services—including pharmaceutical development, manufacturing, and analytical testing—to other businesses. Its strategic focus areas for specialty product distribution include dermatology, women's health, and infectious disease treatments. Originally established in 2005, the company operated under the name Halcygen Pharmaceuticals Limited before rebranding to Mayne Pharma Group Limited in November 2010. Its principal office is located in Salisbury South, Australia.
Show more...
CEO
Aaron Gray
Employees
450
Country
Australia
ISIN
AU000000MYX0
WKN
000A1C821

Listings

STU
DE
HG6.STU
AU
AU
MYX.AU
OTC Link
US
MAYNF
F
DE
HG6.F

0 Comments

Share your thoughts

FAQ

What is Mayne Pharma Group Limited stock price today?▼
The current price of MAYNF is $2.35 USD — it has decreased by -0.84% in the past 24 hours. Watch Mayne Pharma Group Limited stock price performance more closely on the chart.
What is Mayne Pharma Group Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Mayne Pharma Group Limited stocks are traded under the ticker MAYNF.
Is Mayne Pharma Group Limited stock price growing?▼
MAYNF stock has risen by +1.73% compared to the previous week, the month change is a +3.07% rise, over the last year Mayne Pharma Group Limited has showed a -31.59% decrease.
What is Mayne Pharma Group Limited market cap?▼
Today Mayne Pharma Group Limited has the market capitalization of 190.93M
When is the next Mayne Pharma Group Limited earnings date?▼
Mayne Pharma Group Limited is going to release the next earnings report on February 24, 2027.
What were Mayne Pharma Group Limited earnings last quarter?▼
MAYNF earnings for the last quarter are -0.25 USD per share, whereas the estimation was -0.24 USD resulting in a -6.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Mayne Pharma Group Limited revenue for the last year?▼
Mayne Pharma Group Limited revenue for the last year amounts to 258.19M USD.
What is Mayne Pharma Group Limited net income for the last year?▼
MAYNF net income for the last year is -60.93M USD.
Does Mayne Pharma Group Limited pay dividends?▼
Yes, MAYNF dividends are paid quarterly. The last dividend per share was 0.39 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Mayne Pharma Group Limited have?▼
As of September 04, 2026, the company has 450 employees.
In which sector is Mayne Pharma Group Limited located?▼
Mayne Pharma Group Limited operates in the Health & Wellness sector.
When did Mayne Pharma Group Limited complete a stock split?▼
The last stock split for Mayne Pharma Group Limited was on January 18, 2023 with a ratio of 1:20.
Where is Mayne Pharma Group Limited headquartered?▼
Mayne Pharma Group Limited is headquartered in Salisbury South, Australia.